< 0.001), accompanied by 32% and 33% reductions in embryonic length and weight, respectively. These results underscore the synergistic potential of CS-Se-Cu NPs as dual cytotoxic and anti-angiogenic agents for liver cancer therapy.
Shahbur et al. (Fri,) studied this question.